Vemurafenib

CAS 1029872-54-5

Also known as: VeMurafenib PLX 4032 Zelboraf

Verofinil is a small molecule BRAF kinase inhibitor, which can selectively bind to the ATP binding domain of the mutant BRAF, thus inhibiting the activation of the enzyme. The U.S. Food and Drug Administration (FDA) has approved verofinil for the treatment of malignant melanoma with BRAF gene mutation.

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: vemurafenib-1029872-54-5
Payment & Shipping Terms Supply Capacity
Payment Terms: T/T, WU Production Capacity: 1000kg/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Vemurafenib

CAS 1029872-54-5

Verofinil is a small molecule BRAF kinase inhibitor, which can selectively bind to the ATP binding domain of the mutant BRAF, thus inhibiting the activation of the enzyme. The U.S. Food and Drug Administration (FDA) has approved verofinil for the treatment of malignant melanoma with BRAF gene mutation.

We can customize according to customer's requirement

if you have any question pls mail us or call us.

CAS Number 1029872-54-5
Molecular Formula C23H18ClF2N3O3S
Molecular Weight 489.92
Place of Origin Zhejiang,China (Mainland)
Specification CP/USP/EP
Request a quote

Send an inquiry for Vemurafenib

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP